Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Genetron Healths' biochip reader GENETRON 3D had received the approval for launch to facilitate liquid biopsy of tumor 2018-08-22 14:38
IDH "Encyclopedic" Research Review Debuts in Academic Journal, Cancer Cell 2018-08-22 12:01
Systech Asserts Leadership Position in Blockchain Solutions for the Pharmaceutical Supply Chain 2018-08-22 02:57
PeriCoach(r) Real-World Data Analysis Reveals Statistically and Clinically Significant Reduction in Incontinence Symptoms Within 3 Weeks 2018-08-21 21:56
NeuroVive Pharmaceutical AB Interim Report January - June 2018 2018-08-21 15:22
Lower price for nutrition assessment tool expands global access 2018-08-20 21:00
CSPC Pharmaceutical Announces 2018 Interim Results 2018-08-20 16:30
Singapore's first clinical trial approval for T cell engineered (TCR) immunotherapy for treatment of Liver cancer 2018-08-20 09:00
Global Cord Blood Corporation Announces the Results of Scrip Dividend Elections 2018-08-18 05:30
Global Cord Blood Corporation to Report First Quarter Fiscal 2019 Financial Results 2018-08-16 18:00
Surescripts Recognized by Frost & Sullivan for Revolutionizing E-Prescribing with Prescription Price Transparency and Authorization at the Point of Care 2018-08-15 20:30
Merck Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Technology 2018-08-15 20:00
Mundipharma brings its cancer supportive care expertise to Vietnam after signing agreement with Helsinn Group for ALOXI(R) (palonosetron HCl) 2018-08-15 18:21
Stealth BioTherapeutics Expands Pipeline, Advances New Compound 2018-08-15 00:00
The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease 2018-08-14 22:00
Kaneka officially starts continuous manufacturing under GMP 2018-08-14 07:48
JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Trastuzumab Biosimilar to Treat Breast Cancer 2018-08-10 10:05
JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Bevacizumab Biosimilar to Treat Lung Cancer 2018-08-10 09:24
NCCN Publishes First-Ever U.S. Guidelines for Rare Cancers Associated with Pregnancy 2018-08-09 21:15
Frost & Sullivan Publishes Quarterly Update on Oramed Pharmaceuticals Inc. - Sufficient funds for clinical development activity over the next 24 months; several clinical milestones are scheduled for 2018 and 2019; as Oramed's clinical progress meets our expectations, stock target price remains at NIS 53.2. 2018-08-07 20:00
1 452 453 454 455 456 531